Atea plunges after COVID-19 treatment fails to help patients in study
Atea Pharmaceuticals Inc's experimental COVID-19 antiviral pill, being developed with Roche, failed to help patients with mild and moderate COVID-19 in a small study of mostly low-risk patients,... | October 19, 2021